MD News and Press, Mednax Inc. From 02/18/21

Mednax (MD): Q4 Non-GAAP EPS of $0.25 misses by $0.11; GAAP EPS of $0.05 misses by $0.06.Revenue of $417M (-9.1% Y/Y) misses by $43.29M.Press Release For further details see: Mednax EPS misses by $0.11, misses on revenue

Mednax, Inc. (NYSE: MD), the national medical group specializing in prenatal, neonatal, and pediatric services, today reported earnings from continuing operations of $0.05 per share for the three months ended December 31, 2020. On a non-GAAP basis, Mednax reported Adjusted EPS from cont...

Mednax (NYSE:MD) is scheduled to announce Q4 earnings results on Thursday, February 18th, before market open.The consensus EPS Estimate is $0.36 (-60.4% Y/Y) and the consensus Revenue Estimate is $460.29M (-49.2% Y/Y).Over the last 2 years, MD has beaten EPS estimates 50% of the time and has ...

Mednax, Inc. (NYSE: MD) will host an investor conference call and webcast on Thursday, February 18, 2021 at 9:00 a.m. ET, to discuss results from operations for the quarter and the year ended December 31, 2020. A detailed press release will be issued the morning of February 18, 2021 bef...

Premier neonatology meeting moves to a new virtual format, continuing its longstanding tradition of addressing the latest topics in neonatal management to improve newborn outcomes Mednax, Inc. (NYSE: MD), the national health solutions partner specializing in prenatal, neonat...

The law firm of Federman & Sherwood has filed the first data breach case against MedNax, Inc. (“MedNax”) (NYSE: MD) and Pediatrix Medical Group, a MedNax Company (“Pediatrix”) with respect to possible violations of state and federal consumer laws for a da...

Silver Ring Value Partners Limited Partnership provides investment advisory services. The Company offers portfolio management, financial planning, and trading services. Silver Ring Value Partners serves investors in the State of Massachusetts. Despite the market heavily favoring high-...

A 20-year back-testing study of my annual index for US-listed quality stocks reveals remarkably consistent outperformance on a risk-adjusted basis: Up to 21.1% in average annualized returns, 4.8% annualized alpha, average max drawdown of 8.8%, average Sortino ratio of 3.89, and an ave...

MEDNAX (MD) completes the previously announced sale of MEDNAX Radiology Solutions to Radiology Partners for total consideration of $885M.The Company received net proceeds of ~$865M and the proceeds will be used to redeem its $750M in outstanding principal amount of 5.25% senior notes due...

MEDNAX, Inc. (NYSE: MD), the national health solutions partner specializing in prenatal, neonatal, and pediatric services, today announced that it has completed the previously announced sale of MEDNAX Radiology Solutions to Radiology Partners for total consideration of $885 million. The...